Media Summary: CANCER TREATMENT SUCCESS STORY Watch this incredible journey from terminal cancer diagnosis to clear scans using ... REGIONAL CANCER STORY A regional Victorian patient shares his journey with We've released a new episode in our Science Series to dive into some of the groundbreaking work happening at

Imugene Azer Cel Trial Shows - Detailed Analysis & Overview

CANCER TREATMENT SUCCESS STORY Watch this incredible journey from terminal cancer diagnosis to clear scans using ... REGIONAL CANCER STORY A regional Victorian patient shares his journey with We've released a new episode in our Science Series to dive into some of the groundbreaking work happening at We held an investor webinar on Tuesday 22 August 2023 at 11am AEST. The session was hosted by our Managing Director and ...

Photo Gallery

Imugene azer-cel trial shows complete response
Imugene Azer-cel CAR-T Trial Featured on 10 News | Patient Story
Azer-cel Patient Story: Hope for Regional Cancer Patients | Imugene | WIN News
Imugene CEO on Phase 1b azer-cel data: second complete response
Science Series with Imugene CMO John Byon and, Azer-cel Phase 1b trial Dr Joseph Maakaron
Imugene’s Azer-cel Granted FDA Fast Track Designation for Blood Cancer Treatment
Investor webinar: Azer-cel trial update, September 2024
Imugene reports promising results in Phase 1b trial for azer-cel in DLBCL
Investor webinar: Azer-cel new data, July 2025
Imugene’s ASX  IMU azer cel CAR T therapy trial shows encouraging results in blood cancer
Imugene’s Phase 1b Azer cel trial 57% complete response rate
Imugene’s Leslie Chong talks Azer-cel breakthrough
View Detailed Profile
Imugene azer-cel trial shows complete response

Imugene azer-cel trial shows complete response

Imugene

Imugene Azer-cel CAR-T Trial Featured on 10 News | Patient Story

Imugene Azer-cel CAR-T Trial Featured on 10 News | Patient Story

CANCER TREATMENT SUCCESS STORY Watch this incredible journey from terminal cancer diagnosis to clear scans using ...

Azer-cel Patient Story: Hope for Regional Cancer Patients | Imugene | WIN News

Azer-cel Patient Story: Hope for Regional Cancer Patients | Imugene | WIN News

REGIONAL CANCER STORY A regional Victorian patient shares his journey with

Imugene CEO on Phase 1b azer-cel data: second complete response

Imugene CEO on Phase 1b azer-cel data: second complete response

Imugene

Science Series with Imugene CMO John Byon and, Azer-cel Phase 1b trial Dr Joseph Maakaron

Science Series with Imugene CMO John Byon and, Azer-cel Phase 1b trial Dr Joseph Maakaron

We've released a new episode in our Science Series to dive into some of the groundbreaking work happening at

Imugene’s Azer-cel Granted FDA Fast Track Designation for Blood Cancer Treatment

Imugene’s Azer-cel Granted FDA Fast Track Designation for Blood Cancer Treatment

Imugene

Investor webinar: Azer-cel trial update, September 2024

Investor webinar: Azer-cel trial update, September 2024

Watch the replay of

Imugene reports promising results in Phase 1b trial for azer-cel in DLBCL

Imugene reports promising results in Phase 1b trial for azer-cel in DLBCL

Imugene

Investor webinar: Azer-cel new data, July 2025

Investor webinar: Azer-cel new data, July 2025

Watch the replay of

Imugene’s ASX  IMU azer cel CAR T therapy trial shows encouraging results in blood cancer

Imugene’s ASX IMU azer cel CAR T therapy trial shows encouraging results in blood cancer

Imugene

Imugene’s Phase 1b Azer cel trial 57% complete response rate

Imugene’s Phase 1b Azer cel trial 57% complete response rate

Imugene

Imugene’s Leslie Chong talks Azer-cel breakthrough

Imugene’s Leslie Chong talks Azer-cel breakthrough

Imugene

Imugene Investor Webinar | Acquisition of License for Azer-Cel Cell Therapy

Imugene Investor Webinar | Acquisition of License for Azer-Cel Cell Therapy

We held an investor webinar on Tuesday 22 August 2023 at 11am AEST. The session was hosted by our Managing Director and ...